Evonik Evonik

X

Find the latest Drugs in Development and Pipeline Prospector News of Chroma Dermatology.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Chroma Dermatology
Australia Flag
Country
Country
Australia
Address
Address
532 Doncaster Rd Doncaster Vic 3108
Telephone
Telephone
+61 3 8560 6946
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

Acquisition of clinical-stage biotechnology company Chromaderm by DermBiont, will accelerate the development of Chromaderm’s drug candidate, ruboxistaurin (SM-030), topical formulation of the first and only targeted drug to treat skin hyperpigmentation.


Lead Product(s): Ruboxistaurin

Therapeutic Area: Dermatology Product Name: SM-030

Highest Development Status: Phase IProduct Type: Small molecule

Partner/Sponsor/Collaborator: DermBiont

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Acquisition December 21, 2021

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY